Concepedia

Lucia Correa

LC

Statistics

Publications

26

Citations

1.1K

H-Index

18

Active since

1996

Affiliations

General Atomics (United States)(Current)

Incept (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Neurosciences Institute

Amplyx Pharmaceuticals (United States)

Lucia Correa is an author at General Atomics (United States) specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

1996–2017

26

Publications

26

Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist

J. S. Swaney, Charles W. Chapman, Lucia Correa et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 126 citations

, , +11

Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (NAChR) ligands in the rat tail-flick assay

Tadimeti S. Rao, Lucia Correa, Richard T. Reid et al. · Neuropharmacology · 1996 · 96 citations

, , +16

Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge

Daniel S. Lorrain, Hervé Schaffhauser, Una C. Campbell et al. · Neuropsychopharmacology · 2003 · 94 citations · Full text

, , +9

(<i>S</i>)-(−)-5-Ethynyl-3-(1-methyl-2-pyrroli- dinyl)pyridine Maleate (SIB-1508Y):  A Novel Anti-Parkinsonian Agent with Selectivity for Neuronal Nicotinic Acetylcholine Receptors

Nicholas D. P. Cosford, Leo Bleicher, Audrey Herbaut et al. · Journal of Medicinal Chemistry · 1996 · 92 citations · Full text

, , +13

Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists

Tadimeti S. Rao, Lucia Correa, Pamala Adams et al. · Brain Research · 2003 · 74 citations

, , +17

1–5 of 26